美國NovaBios埃博拉病毒檢測試劑（西非）

廣州健侖生物科技有限公司

本司長期供應埃博拉病毒檢測試劑盒，其主要品牌包括美國NovaBios、廣州創侖等CDC使用的進口產品，試劑盒的實驗方法包括膠體金方法、ELISA方法、PCR方法等。

歡迎咨詢

歡迎咨詢2042552662

埃博拉病毒IgM、IgG、ELISA檢測試劑、埃博拉快速檢測試劑盒、

埃博拉病毒核酸檢測試劑盒（熒光探針PCR）

西非工作、旅游埃博拉檢測試劑盒

美國CDC使用的埃博拉診斷試劑——美國的NovaBios

美國NovaBios 埃博拉病毒檢測試劑（西非）

【埃博拉簡介】

埃博拉（Ebola virus）又譯作伊波拉病毒。是一種十分罕見的病毒，1976年在蘇丹南部和剛果（金）（舊稱扎伊爾）的埃博拉河地區發現它的存在后，引起醫學界的廣泛關注和重視，“埃博拉”由此而得名。是一個用來稱呼一群屬于纖維病毒科埃博拉病毒屬下數種病毒的通用術語。是一種能引起人類和靈長類動物產生埃博拉出血熱的烈性傳染病病毒，有很高的死亡率，在50%至90%之間，致死原因主要為中風、心肌梗塞、低血容量休克或多發性器官衰竭。

埃博拉出血熱（EBHF）是由一種絲狀病毒感染導致的急性出血性、動物源性傳染病。1976年，埃博拉出血熱在非洲的蘇丹和扎伊爾暴發，病死率高達50% ～ 90% 。因該病始發于扎伊爾北部的埃博拉河流，并在該區域嚴重流行，故命名為埃博拉病毒，其形態學、致病性等與馬爾堡病毒相似，但免疫原性有所區別。

【產品介紹】

該產品是世界衛生組織（WHO）*個批準用于埃博拉病毒檢測的診斷試劑卡。不需要借助其他實驗儀器設備，只需要采取幾滴血清、血漿、血液樣品，既可以檢測，并在15分鐘內就可以得知結果是否感染埃博拉病毒。該產品具有靈敏度高、操作方便、實驗時間短等特點。

美國NovaBios

另一種更為精確的方法是，只計算那些同時感染了，又經歷了足夠長的時間，以至于要么死于病癥要么恢復出院的人的zui終結果。這樣的計算，自然更接近于死亡率的定義與本質。Rambaut注意到，Science上一篇研究埃博拉病毒的變異的報告中，今年五月底開始的一次地區性爆發中共確診了78名埃博拉患者，23名存活下來。也就是說今年爆發的埃博拉病毒實際致死率應為70%。值得注意的是，這份報告由來自四個國家的五十多名奮戰在一線的醫療工作者共同完成，其中五名共同作者并沒有等到文章在Science上的發表。因為他們在研究與等待上線過程中已經感染了埃博拉埃博拉病毒了。
　　世界衛生組織戰略部主管Christopher Dye說，目前組織正在轉向這個測算方法，并在為將每一個病患的記錄都整理為護理案例而努力。Dye說，“我們需要zui有效的估計。我們想知道埃博拉在這次爆發中的致死率，是否與之前在中非的幾次爆發有所不同，以及目前爆發中不同的治療方案是否有不同的效果。”
　　不過，即使這個方法依然是不夠*的。在大多數疾病爆發中，由于病患并沒有尋求醫療機構的幫助而導致統計案例缺失，從而帶來致死率估計的偏差。Lipsitch認為，這種偏差可能是偏大的，也可能是偏小的。許多案例的病情相對溫和——感染患者并不需要看醫生就能自行康復——因此統計到的數據高估了實際死亡率(這正是墨西哥H1N1流感爆發時的情況，專家懷疑中東呼吸綜合征爆發時也存在這種情況)。不過Lipsitch也說，溫和版的埃博拉不大可能像溫和版流感那樣難以發現，只是考慮到這些地方整體缺少醫療條件，有可能存在一定數量的自愈患者沒有被統計到。
　　另一方面，研究者注意到許多埃博拉感染者還沒去到醫院已經死在家中(通常還感染了其他家庭成員和照顧者)。這意味著他們的死亡并沒有被計算——從而低估了致死率。
　　到底有多少未被記錄的埃博拉病毒死亡病例發生，我們將永遠不得而知。衛生官員正在跟蹤疑似病例和可能病例，其中有許多是在被確診為埃博拉之前已經死了的。是否將這些案例放在致死率計算中是另一個潛在的誤差來源。另外，確診測試在不同的地區有不同的模式：例如，有些地方已經做了更多的驗尸測試。Lipsitch說：“怎么在這些誤差中保持平衡始終是一個大問題”

美國NovaBios

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

想了解更多的NovaBios產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

Another more precise way is to calculate only those who are infected at the same time, and have experienced a long enough time to either die from the disease or to restore the final outcome of the person discharged. This calculation is naturally closer to the definition and nature of mortality. Rambaut noted that in a recent study of the latest mutation in the study of the Ebola virus, a regional outbreak began at the end of May this year, and 78 of the Ebola patients were diagnosed and 23 survived. That is the outbreak of Ebola virus this year, the actual mortality rate should be 70%. It is worth noting that the report was completed by more than 50 health workers from four countries in the first line, five of whom did not wait until the article was published in Science. Because they are in the process of research and waiting on the line has been infected with the Ebola Ebola virus.
Christopher Dye, head of the World Health Organization's strategy, says the organization is now turning to this approach and working hard to organize every patient's record into a nursing case. "We need the most effective estimate," Dye said, "and we want to know whether the lethality of Ebola in this outbreak is different from the previous outbreaks in Central Africa and whether there are different treatments in the current outbreak Different effect. "
However, even if this method is still not perfect. In most disease outbreaks, the absence of statistical cases resulted in deviations from the estimated mortality rate because the patient did not seek the help of a medical institution. Lipsitch believes that this deviation may be too large, it may be too small. In many cases the condition is relatively mild - the infected patient does not need to see a doctor to be able to recover on his own - so the statistical data overestimate the actual mortality rate (which is the case when the H1N1 flu outbreak in Mexico, experts suspected Middle East Respiratory Syndrome Outbreak when there is such a situation). But Lipsitch also said that the modest version of Ebola is unlikely to be as hard as the fluvial flu, just taking into account the overall lack of medical conditions in these places, there may be a certain number of self-healing patients have not been counted to.
On the other hand, the researchers note that many Ebola-infected people have not yet gone to the hospital that have died at home (usually also infected with other family members and caregivers). This means that their death has not been calculated - thus underestimating the lethality.
How many unrecognized Ebola virus deaths occurred in the end, we will never know. Health officials are tracking suspected cases and possible cases, many of which are already dead before being diagnosed with Ebola. Whether these cases are placed in the lethality calculation is another potential source of error. In addition, diagnostic tests have different patterns in different areas: for example, some places have done more autopsy tests. Lipsitch said: "how to balance in these errors is always a big problem"